Results 271 to 280 of about 240,256 (373)
Abstract Background Rett syndrome (RTT) is a rare neurodevelopmental disorder linked with MECP2 variants, frequently presenting with movement disorders (MDs). Objectives This study examined the frequency, types, and associations of MDs with RTT characteristics and severity.
Silvia Boeri+5 more
wiley +1 more source
Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson's disease model. [PDF]
Lim HS+6 more
europepmc +1 more source
Stroke Mimicking Thalamotomy in Primary Familial Brain Calcification
Movement Disorders Clinical Practice, EarlyView.
Jaakko Kungshamn+4 more
wiley +1 more source
Abstract Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a well‐established therapy in advanced Parkinson's disease (PD) improving motor and non‐motor signs including sleep. The mechanisms of sleep improvement are insufficiently understood.
Julia Steinhardt+6 more
wiley +1 more source
Protective Role of Whey Protein Isolate on MPP<sup>+</sup>-Induced Differentiation of SH-SY5Y Cells by Modulating the Nrf2 Antioxidant Pathway. [PDF]
Rungruang P, Sroyraya M, Sansri V.
europepmc +1 more source
Effects of experimental cerebral ischemia on striatal dopaminergic neurons.
Hiroshi Yao+4 more
openalex +2 more sources
Argument for a non‐linear relationship between severity of human obesity and dopaminergic tone
Annette Horstmann, W. Fenske, M. Hankir
semanticscholar +1 more source